BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 33669336)

  • 1. The Multi-Targeting Ligand ST-2223 with Histamine H
    Eissa N; Venkatachalam K; Jayaprakash P; Falkenstein M; Dubiel M; Frank A; Reiner-Link D; Stark H; Sadek B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histamine H3R and dopamine D2R/D3R antagonist ST-713 ameliorates autism-like behavioral features in BTBR T+tf/J mice by multiple actions.
    Venkatachalam K; Eissa N; Awad MA; Jayaprakash P; Zhong S; Stölting F; Stark H; Sadek B
    Biomed Pharmacother; 2021 Jun; 138():111517. PubMed ID: 33773463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous Antagonism at H3R/D2R/D3R Reduces Autism-like Self-Grooming and Aggressive Behaviors by Mitigating MAPK Activation in Mice.
    Eissa N; Awad MA; Thomas SD; Venkatachalam K; Jayaprakash P; Zhong S; Stark H; Sadek B
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Blockade of Histamine H
    Eissa N; Jayaprakash P; Stark H; Łażewska D; Kieć-Kononowicz K; Sadek B
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32872194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Dual-Active Histamine H
    Eissa N; Azimullah S; Jayaprakash P; Jayaraj RL; Reiner D; Ojha SK; Beiram R; Stark H; Łażewska D; Kieć-Kononowicz K; Sadek B
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.
    Eissa N; Jayaprakash P; Azimullah S; Ojha SK; Al-Houqani M; Jalal FY; Łażewska D; Kieć-Kononowicz K; Sadek B
    Sci Rep; 2018 Aug; 8(1):13077. PubMed ID: 30166610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine H3 receptor antagonism modulates autism-like hyperactivity but not repetitive behaviors in BTBR T+Itpr3tf/J inbred mice.
    Molenhuis RT; Hutten L; Kas MJH
    Pharmacol Biochem Behav; 2022 Jan; 212():173304. PubMed ID: 34856309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin 6 receptor blockade reduces repetitive behavior in the BTBR mouse model of autism spectrum disorder.
    Amodeo DA; Oliver B; Pahua A; Hitchcock K; Bykowski A; Tice D; Musleh A; Ryan BC
    Pharmacol Biochem Behav; 2021 Jan; 200():173076. PubMed ID: 33220385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of Autism.
    Eissa N; Venkatachalam K; Jayaprakash P; Yuvaraju P; Falkenstein M; Stark H; Sadek B
    Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 36015079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin Potentiates α7 Nicotinic Acetylcholine Receptors and Alleviates Autistic-Like Social Deficits and Brain Oxidative Stress Status in Mice.
    Jayaprakash P; Isaev D; Shabbir W; Lorke DE; Sadek B; Oz M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice.
    Eissa N; Azimullah S; Jayaprakash P; Jayaraj RL; Reiner D; Ojha SK; Beiram R; Stark H; Łażewska D; Kieć-Kononowicz K; Sadek B
    Chem Biol Interact; 2019 Oct; 312():108775. PubMed ID: 31369746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adenosine A
    Amodeo DA; Cuevas L; Dunn JT; Sweeney JA; Ragozzino ME
    Autism Res; 2018 Feb; 11(2):223-233. PubMed ID: 29193861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the expression of restricted repetitive behaviors in female and male BTBR T + tf/J mice.
    Amodeo DA; Pahua AE; Zarate M; Taylor JA; Peterson S; Posadas R; Oliver BL; Amodeo LR
    Behav Brain Res; 2019 Oct; 372():112028. PubMed ID: 31212059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-aminoisoquinolinone attenuates social behavior deficits and immune abnormalities in the BTBR T
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alqahtani F; Alhoshani AR; Alasmari F; Alsaleh NB; Attia SM
    Pharmacol Biochem Behav; 2020 Feb; 189():172859. PubMed ID: 31982447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Nicotinic Receptors in the Attenuation of Autism-Related Behaviors in a Murine BTBR T + tf/J Autistic Model.
    Mahmood HM; Aldhalaan HM; Alshammari TK; Alqasem MA; Alshammari MA; Albekairi NA; AlSharari SD
    Autism Res; 2020 Aug; 13(8):1311-1334. PubMed ID: 32691528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the Partial M1 Muscarinic Cholinergic Receptor Agonist CDD-0102A on Stereotyped Motor Behaviors and Reversal Learning in the BTBR Mouse Model of Autism.
    Athnaiel O; Job GA; Ocampo R; Teneqexhi P; Messer WS; Ragozzino ME
    Int J Neuropsychopharmacol; 2022 Jan; 25(1):64-74. PubMed ID: 34791301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M100907 attenuates elevated grooming behavior in the BTBR mouse.
    Amodeo DA; Rivera E; Dunn JT; Ragozzino ME
    Behav Brain Res; 2016 Oct; 313():67-70. PubMed ID: 27378338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium phenylbutyrate reduces repetitive self-grooming behavior and rescues social and cognitive deficits in mouse models of autism.
    Ryu YK; Park HY; Go J; Choi DH; Choi YK; Rhee M; Lee CH; Kim KS
    Psychopharmacology (Berl); 2021 Jul; 238(7):1833-1845. PubMed ID: 33723660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram attenuates social behavior deficits in the BTBR T
    Cai Y; Wang L; Nalvarte I; Xiao R; Li X; Fan X
    Brain Res Bull; 2019 Aug; 150():75-85. PubMed ID: 31047973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP.
    Silverman JL; Tolu SS; Barkan CL; Crawley JN
    Neuropsychopharmacology; 2010 Mar; 35(4):976-89. PubMed ID: 20032969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.